# ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

> **NCT03172156** · — · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 100 (actual)

## Conditions studied

- Non-small Cell Lung Cancer Stage I

## Interventions

- **GENETIC:** ctDNA detection

## Key facts

- **NCT ID:** NCT03172156
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2020-02-01
- **Final completion:** 2020-02-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03172156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03172156, "ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03172156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
